bms204352 has been researched along with lapatinib in 1 studies
Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) |
---|---|---|---|---|---|
49 | 1 | 12 | 1,919 | 305 | 1,442 |
Protein | Taxonomy | bms204352 (IC50) | lapatinib (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 7.375 | |
Epidermal growth factor receptor | Homo sapiens (human) | 0.0827 | |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.0537 | |
Platelet-derived growth factor receptor beta | Homo sapiens (human) | 8.5 | |
D(1A) dopamine receptor | Sus scrofa (pig) | 0.06 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1 | |
Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | 0.1659 | |
Alpha-1A adrenergic receptor | Sus scrofa (pig) | 0.06 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
1 other study(ies) available for bms204352 and lapatinib
Article | Year |
---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |